Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients

Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab

(2014) T. Koudriavtseva et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

MicroRNAs Within the Continuum of Postgenomics Biomarker Discovery

(2013) Manuel Mayr et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis

(2013) A. Reijerkerk et al.   JOURNAL OF NEUROSCIENCE

L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients

(2013) N. Schwab et al.   NEUROLOGY

MicroRNAs may solve the mystery of chronic hepatitis B virus infection

(2013) Ying-Feng Wei   WORLD JOURNAL OF GASTROENTEROLOGY

Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients

(2012) Cinzia Zanotti et al.   CLINICAL IMMUNOLOGY

Altered microRNA expression in B lymphocytes in multiple sclerosis

(2012) Claudia Sievers et al.   CLINICAL IMMUNOLOGY

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

The potential role of microRNA-146 in Alzheimer’s disease: Biomarker or therapeutic target?

(2011) Li-Ling Wang et al.   MEDICAL HYPOTHESES

NAViGaTing the Micronome – Using Multiple MicroRNA Prediction Databases to Identify Signalling Pathway-Associated MicroRNAs

(2011) Elize A. Shirdel et al.   PLoS One

Natalizumab and Progressive Multifocal Leukoencephalopathy

(2010) Clemens Warnke et al.   ARCHIVES OF NEUROLOGY

Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor

(2010) Y. Benita et al.   BLOOD

Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells

(2010) Norman Putzki et al.   EUROPEAN NEUROLOGY

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

(2009) Gabriela Bindea et al.   BIOINFORMATICS

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47

(2009) Andreas Junker et al.   BRAIN

Revisiting the principles of microRNA target recognition and mode of action

(2009) Peter Brodersen et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls

(2009) Andreas Keller et al.   PLoS One

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

(2008) Raija L.P. Lindberg et al.   JOURNAL OF NEUROIMMUNOLOGY

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

(2008) M. Krumbholz et al.   NEUROLOGY